Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
News
Nature Biotechnology 22, 1061 (1 September 2004) | doi:10.1038/nbt0904-1061
EU to review rare disease drugs market exclusivity
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
